The Thymus (T)-Cell Therapy Market growth at a CAGR of 18.55% & expected USD 21.28 billion by 2029. It is analyzed as modality, therapy, indication, end-users and distribution channel.
Chimeric Antigen Receptor (CAR)-T Cell Therapy Market was valued at USD 2.19 billion in 2022 and would grow to USD 5.35 billion and is growing at a 11.8% by 2030.